Korngold R
Department of Microbiology and Immunology, Jefferson Cancer Institute, Jefferson Medical College, Philadelphia, PA 19107.
Bone Marrow Transplant. 1992 May;9(5):355-64.
Lethal graft-versus-host disease (GVHD) can be induced in MHC-matched strain combinations which differ in their expression of multiple minor histocompatibility (H) antigens. It has been shown that CD8+ T cells play an important role in the development of disease directed to the minor H antigens, and that initial indications were that highly purified preparations of these cells were capable of mediating GVHD, without apparent 'help' from mature donor-derived CD4+ T cells. To further strengthen this hypothesis, the current study was undertaken with the B10.BR----CBA strain combination in which irradiated recipient mice were additionally treated with an anti-CD4 monoclonal antibody, as a single or repeated injection, to minimize the presence of either residual host CD4+ cells or recently generated donor-derived CD4+ cells at later stages of disease development. The results indicate that these treatments do not affect the GVHD outcome and that the CD8+ cells are indeed capable of inducing disease independent of CD4+ 'help'. The addition of donor CD4+ T cells in the inoculum, however, does enhance the potential of these CD8+ cells, and is observed with both low and high dosages of CD4+ cells. CD4+ T cells, on their own, have also been observed to cause GVHD directed to minor H antigens in certain strain combinations, and their response has been further characterized in this study. Results indicate that CD4+ cells capable of mediating GVHD in the B10.D2----DBA/2 strain combination can do so over a wide range of recipient irradiation exposures. The transfer of high dosages of CD4+ cells only shortens survival times of the recipients and does not afford any apparent protection phenomenon as previously observed in CD4+ cell mediated anti-class II MHC GVHD. The study also indicates that neither CD4+ nor CD8+ cells responsible for GVHD directed to minor H antigens seem capable of targeting host stem cell elements.
致死性移植物抗宿主病(GVHD)可在多个次要组织相容性(H)抗原表达不同的主要组织相容性复合体(MHC)匹配品系组合中诱发。已表明,CD8⁺T细胞在针对次要H抗原的疾病发展中起重要作用,而且初步迹象显示,这些细胞的高度纯化制剂能够介导GVHD,而无需来自成熟供体来源的CD4⁺T细胞的明显“辅助”。为进一步强化这一假说,本研究采用B10.BR----CBA品系组合进行,其中对受照射的受体小鼠额外给予抗CD4单克隆抗体,单次或重复注射,以尽量减少疾病发展后期残留宿主CD4⁺细胞或新产生的供体来源CD4⁺细胞的存在。结果表明,这些处理不影响GVHD的结果,而且CD8⁺细胞确实能够独立于CD4⁺“辅助”诱导疾病。然而,在接种物中加入供体CD4⁺T细胞确实会增强这些CD8⁺细胞的潜力,并且在低剂量和高剂量的CD4⁺细胞中均观察到这种情况。还观察到,CD4⁺T细胞自身在某些品系组合中也会引发针对次要H抗原的GVHD,并且在本研究中对其反应进行了进一步表征。结果表明,在B10.D2----DBA/2品系组合中能够介导GVHD的CD4⁺细胞在广泛的受体照射剂量范围内均可如此。高剂量CD4⁺细胞的转移只会缩短受体的存活时间,并且不会像先前在CD4⁺细胞介导的抗II类MHC GVHD中观察到的那样提供任何明显的保护现象。该研究还表明,负责针对次要H抗原的GVHD的CD4⁺和CD8⁺细胞似乎均无法靶向宿主干细胞成分。